moddus start flydende middel
syngenta nordics a/s - trinexapac-ethyl, trinexapac - flydende middel - 250 g/l trinexapac-ethyl ; (~ 222 g/l trinexapac)
efedrin "unimedic" 5 mg/ml injektionsvæske, opløsning
unimedic pharma ab - ephedrinhydrochlorid - injektionsvæske, opløsning - 5 mg/ml
pirimor 500 wg vanddispergerbart granulat
adama northern europe b.v. - pirimicarb - vanddispergerbart granulat - 500 g/kg pirimicarb
qtrilmet
astrazeneca ab - metformin hydrochlorid, saxagliptin, dapagliflozin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - qtrilmet er indiceret hos voksne i alderen 18 år og ældre med type 2-diabetes mellitus:at forbedre glykæmisk kontrol, når metformin med eller uden sulphonylurea (su) og enten saxagliptin eller dapagliflozin ikke giver tilstrækkelig glykæmisk kontrol. når du allerede er i behandling med metformin og saxagliptin og dapagliflozin.
ephedrine "sintetica" 50 mg/ml injektionsvæske, opløsning
sintetica gmbh - ephedrinhydrochlorid - injektionsvæske, opløsning - 50 mg/ml
sebadrin 50 mg/ml injektionsvæske, opløsning
2care4 generics aps - ephedrinhydrochlorid - injektionsvæske, opløsning - 50 mg/ml
mounjaro
eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - narkotika anvendt i diabetes - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 og 5.
edistride
astrazeneca ab - dapagliflozin propandiolmonohydrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotika anvendt i diabetes - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. i tillæg til andre lægemidler til behandling af type 2-diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
efient
substipharm - prasugrel - acute coronary syndrome; angina, unstable; myocardial infarction - antitrombotiske midler - efient, administreret sammen med acetylsalicylsyre (asa), er indiceret til forebyggelse af atherotrombotiske hændelser hos patienter med akut koronarsyndrom (i. ustabil angina, ikke-st-segment-elevation myokardieinfarkt [ua / nstemi] eller st-segment-elevation myokardieinfarkt [stemi]) gennemgår primære eller forsinket perkutan koronar intervention (pci).